(KRYS) Krystal Biotech complete technical analysis [charts+indicators] | Buy/Sell Krystal Biotech | (KRYS) share price targets
Complete technical analysis of Krystal Biotech (KRYS) by charts plus indicators, forecast predictions and share price targets for Krystal Biotech (KRYS)
Krystal Biotech trades in USA in Health Care sector.
Showing technical analysis as on 2025-09-09 View latest technical analysis
10 day averaged volume of Krystal Biotech is 268380
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Tue Sep 2025 | 141.21 | 146.00 | 146.05 | 140.33 | 1.164 times |
| 08 Mon Sep 2025 | 145.20 | 150.21 | 151.45 | 142.91 | 1.206 times |
| 05 Fri Sep 2025 | 150.27 | 150.33 | 152.96 | 149.88 | 1.208 times |
| 04 Thu Sep 2025 | 149.75 | 149.33 | 150.39 | 148.04 | 0.864 times |
| 03 Wed Sep 2025 | 150.20 | 147.98 | 152.57 | 147.62 | 0.975 times |
| 02 Tue Sep 2025 | 149.00 | 148.00 | 150.06 | 145.47 | 1.201 times |
| 29 Fri Aug 2025 | 147.70 | 150.80 | 151.13 | 147.56 | 0.961 times |
| 29 Fri Aug 2025 | 147.70 | 150.80 | 151.14 | 147.56 | 0.961 times |
| 28 Thu Aug 2025 | 150.76 | 147.46 | 151.86 | 147.46 | 0.94 times |
| 27 Wed Aug 2025 | 147.64 | 146.04 | 147.98 | 145.78 | 0.649 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 142.3, for a target of 145.3 or 147.77
Share price targets for Krystal Biotech (KRYS)
| Target Type | Value |
| Downside Target | 122.80 |
| Downside Target | 131.00 |
| Downside Target | 136.44 |
| Downside Target | 140.33 |
| Upside Target | 151.13 |
| Upside Target | 151.86 |
| Upside Target | 152.04 |
| Upside Target | 152.96 |
| Upside Target | 157.00 |
| Upside Target | 159.00 |
| Upside Target | 169.48 |
Intraday share price targets for Krystal Biotech (KRYS)
| Target Type | Value |
| Downside Intraday Target | 137.21 |
| Downside Intraday Target | 133.21 |
| Upside Intraday Target | 148.33 |
| Upside Intraday Target | 155.45 |
| Upside Intraday Target | 144.33 |
Weekly technical analysis of Krystal Biotech (KRYS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Tue Sep 2025 | 141.21 | 150.21 | 151.45 | 140.33 | 0.558 times |
| 05 Fri Sep 2025 | 150.27 | 148.00 | 152.96 | 145.47 | 4.422 times |
| 29 Fri Aug 2025 | 147.70 | 150.80 | 151.13 | 147.56 | 0.202 times |
| 29 Fri Aug 2025 | 147.70 | 150.89 | 151.86 | 143.09 | 1.194 times |
| 22 Fri Aug 2025 | 150.49 | 150.00 | 152.04 | 142.51 | 0.672 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Krystal Biotech (KRYS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Tue Sep 2025 | 141.21 | 148.00 | 152.96 | 140.33 | 0.269 times |
| 29 Fri Aug 2025 | 147.70 | 152.65 | 159.00 | 131.00 | 1.056 times |
| 31 Thu Jul 2025 | 153.87 | 138.46 | 157.00 | 136.44 | 0.819 times |
| 30 Mon Jun 2025 | 137.46 | 125.87 | 146.78 | 124.00 | 0.848 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Krystal Biotech (KRYS)
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Krystal Biotech stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Krystal Biotech in short term but the sell signal is initial and weak.
Krystal Biotech Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Krystal Biotech in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Krystal Biotech is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 147.81 and Krystal Biotech (KRYS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Krystal Biotech (KRYS) stock. Volume based technical analysis of Krystal Biotech (KRYS) stock is negative.
Krystal Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Krystal Biotech stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Krystal Biotech in short term but the sell signal is initial and weak.
Krystal Biotech Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Krystal Biotech in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Krystal Biotech is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 147.81 and Krystal Biotech (KRYS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Krystal Biotech (KRYS) stock. Volume based technical analysis of Krystal Biotech (KRYS) stock is negative.
Krystal Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.